Antioxidant, Anti-Inflammatory, and Antibacterial Properties of an Achillea millefolium L. Extract and Its Fractions Obtained by Supercritical Anti-Solvent Fractionation against Helicobacter pylori
Open Access
- 20 September 2022
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 11 (10) , 1849
Abstract
The main objective of this work is to evaluate the potential utility of an Achillea millefolium extract (yarrow extract, YE) in the control of H. pylori infection. The supercritical anti-solvent fractionation (SAF) process of YE allowed the obtaining of two different fractions: yarrow’s precipitated fraction (YPF), enriched in most polar phenolic compounds (luteolin-7-O-glucoside, luteolin, and 3,5-dicaffeoylquinic acid), and yarrow’s separator fraction (YSF), enriched in monoterpenes and sesquiterpenes, mainly containing camphor, artemisia ketone, and borneol. YE was effective in reducing reactive oxygen species (ROS) production in human gastric AGS cells by 16% to 29%, depending on the H. pylori strain. YPF had the highest inhibitory activity (38–40%) for ROS production. YE modulated the inflammatory response in AGS gastric cells, decreasing IL-8 production by 53% to 64%. This IL-8 inhibition also showed a strain-dependent character. YPF and YSF exhibited similar behavior, reducing IL-8 production, suggesting that both phenolic compounds and essential oils could contribute to IL-8 inhibition. YSF showed the highest antibacterial activity against H. pylori (6.3–7.1 log CFU reduction, depending on the strain) and lower MIC (0.08 mg/mL). Results obtained have shown that YE and SAF fractions (YPF and YSF) were effective as antioxidant, anti-inflammatory, and antibacterial agents regardless of the H. pylori strain characteristics.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (MCIN/AEI/10.13039/501100011033/, ALIBIRD-CM2020 P2018/BAA-4343)
- European Regional Development Fund (MCIN/AEI/10.13039/501100011033/, ALIBIRD-CM2020 P2018/BAA-4343)
- Comunidad de Madrid, Spain (MCIN/AEI/10.13039/501100011033/, ALIBIRD-CM2020 P2018/BAA-4343)
This publication has 52 references indexed in Scilit:
- Antimicrobial susceptibility of 6 antimicrobial agents in Helicobacter pylori clinical isolates by using EUCAST breakpoints compared with previously used breakpointsEnfermedades Infecciosas y Microbiología Clínica, 2017
- Bioactivities ofAchillea millefoliumEssential Oil and Its Main Terpenes from IranInternational Journal of Food Properties, 2016
- Dietary Intervention of Artemisia and Green Tea Extracts to Rejuvenate Helicobacter pylori‐Associated Chronic Atrophic Gastritis and to Prevent TumorigenesisHelicobacter, 2015
- Chemical Composition and Biological Activity of the Volatile Extracts of Achillea millefoliumNatural Product Communications, 2011
- Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pyloriJournal of Ethnopharmacology, 2009
- Comparison of the chemical composition of four yarrow (Achillea millefolium L.) morphotypesBiologija, 2008
- Prevention of lipopolysaccharide-induced injury by 3,5-dicaffeoylquinic acid in endothelial cellsActa Pharmacologica Sinica, 2007
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006
- In Vitro susceptibility ofHelicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disordersPhytotherapy Research, 2005
- Essential Oils as Components of a Diet-Based Approach to Management of Helicobacter InfectionAntimicrobial Agents and Chemotherapy, 2003